Frequency and Patterns of Metastatic Disease in Locally Advanced Inflammatory and Non-inflammatory Breast Cancer

Clinical Oncology

Volumn 23, Issue 9, 2011, Pages 608-612

  Mvere, M Z ^a   James, J J ^a   Cornford, E J ^a   Tennant, S L ^a   Evans, A J ^b   Ellis, I O ^a   Chan, S Y ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Breast Cancer; Imaging; Metastases

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATORY BREAST CANCER; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; METASTASIS; NONINFLAMMATORY BREAST CANCER; PLEURA METASTASIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BREAST NEOPLASMS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80053384931     PISSN: 09366555     EISSN: 14332981     Source Type: Journal    
DOI: 10.1016/j.clon.2011.04.006     Document Type: Article

References (23)

1. Giodarno S.H. Update on locally advanced breast cancer. Oncologist 2003, 8:521-530.
2. Al-Husaini H., Amir E., Fitzgerald B., Wright F. Prevalence of overt metastases in locally advanced breast cancer. Clin Oncol 2008, 20:340-344.
3. West Midlands Cancer Intelligence Unit 0-10 year relative survival for breast cancer by stage diagnosed in the West Midlands 1990-1994 followed up to the end of 2004, as at December 2008 2009, Available at. http://www.wmpho.org.uk/wmciu.
4. Royal College of Radiologists Recommendations for cross-sectional imaging in cancer management 2006, Issue 2, Royal College of Radiologists, London.
5. Sobin L.H., Wittekind C.H. UICC International Union Against Cancer. TNM classification of malignant tumours 2002, Wiley-Liss, New York. 6th edn.
6. Kleer C.G., van Golen K.L., Marajver S.D. Molecular biology of breast cancer metastasis inflammatory breast cancer: clinical syndrome and molecular determinants. Breast Cancer Res 2000, 2:423-429.
7. Lerebours F., Bieche I., Lidereau R. Update on inflammatory breast cancer. Breast Cancer Res 2005, 7:52-58.
8. Robertson F.M., Bondy M., Yang W., et al. Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin 2010, 60:351-375.
9. Puglisi F., Follador A., Minisini A.M., et al. Baseline staging tests after a new diagnosis of breast cancer: further evidence of their limited indications. Ann Oncol 2005, 16:263-266.
10. Dillman R.O., Chico S. Radiologic tests after a new diagnosis of breast cancer. Eff Clin Pract 2000, 3:1-6.
11. Bristow A.R., Agrawal A., Evans A.J., et al. Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? A prospective study. Breast 2008, 17:98-103.
12. Carkaci S., Macapinlac H.A., Cristofanilli M., et al. Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data. J Nucl Med 2009, 50:231-238.
13. Henderson M.A., McBride C.M. Secondary inflammatory breast cancer: treatment options. South Med J 1988, 81:1512-1517.
14. Piera J.M., Alonso M.C., Ojeda M.B., Biete A. Locally advanced breast cancer with inflammatory component: a clinical entity with a poor prognosis. Radiother Oncol 1986, 7:199-204.
15. Kim T., Lau J., Erban J. Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer 2006, 7:386-395.
16. Levine P.H., Veneroso C. The epidemiology of inflammatory breast cancer. Semin Oncol 2008, 35:11-16.
17. Cristofanilli M., Valero V., Bazdar Au, Kau S.W. Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease. Cancer 2007, 110:1436-1444.
18. Brouwers B., Paridaens R., Lobelle J.P., Hendrick W., Smeets A.M., Neven P. Clinicopathological features of inflammatory versus noninflammatory locally advanced nonmetastatic breast cancer. Tumour Biol 2008, 29:211-216.
19. Hance K.W., Anderson W.F., Devesa S.S., Young H.A., Levine P.H. Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005, 97:966-975.
20. Porter G.J.R., Evans A.J., Pinder S.E., et al. Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 2004, 59:1094-1098.
21. James J.J., Evans A.J., Pinder S.E., et al. Bone metastases from breast carcinoma: histological-radiological correlations and prognostic features. Br J Cancer 2003, 89:660-665.
22. Yang W.T., Le-Petross H.T., Macapinlac H., et al. Inflammatory breast cancer: PET/CT, MRI, mammography, and sonography findings. Breast Cancer Res Treat 2008, 109:417-426.
23. D'Alessandro C., Dellapasqua S., Orlando L., et al. Role of endocrine responsiveness and HER2/neu overexpression in inflammatory breast cancer treated with multimodality preoperative therapy. Breast J 2008, 14:435-441.